Methylglyoxal: A Relevant Marker of Disease Activity in Patients with Rheumatoid Arthritis

BACKGROUND: The contribution of methylglyoxal (MGO) and soluble receptor for advanced glycation end products (sRAGE) in the presence of rheumatoid arthritis (RA) is still unknown. We investigated whether serum MGO and sRAGE were related to the presence of disease activity in RA. METHODS: 80 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Knani, Ines, Bouzidi, Hassan, Zrour, Saoussen, Bergaoui, Naceur, Hammami, Mohamed, Kerkeni, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828101/
https://www.ncbi.nlm.nih.gov/pubmed/29606988
http://dx.doi.org/10.1155/2018/8735926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828101/
https://www.ncbi.nlm.nih.gov/pubmed/29606988
http://dx.doi.org/10.1155/2018/8735926

Ejemplares similares